180 Life Sciences Corp. has announced that its 2024 Annual Meeting of Shareholders is scheduled for December 27, 2024. The Board of Directors set the date on October 29, 2024, and noted that the specific time and location details will be included in the definitive proxy statement to be filed with the SEC. Shareholders on record as of October 31, 2024, will be eligible to receive notice and vote at the meeting. The company also outlined the deadline for shareholder proposals and director nominations, which must be received by November 8, 2024, to be considered for inclusion in the proxy materials. Proposals must comply with SEC rules, Delaware law, and the company's bylaws. The announcement was made in a Form 8-K filed with the SEC by Interim CEO Blair Jordan on October 29, 2024.

180 Life Sciences Corp. has announced that its 2024 Annual Meeting of Shareholders is scheduled for December 27, 2024. The Board of Directors set the date on October 29, 2024, and noted that the specific time and location details will be included in the definitive proxy statement to be filed with the SEC. Shareholders on record as of October 31, 2024, will be eligible to receive notice and vote at the meeting. The company also outlined the deadline for shareholder proposals and director nominations, which must be received by November 8, 2024, to be considered for inclusion in the proxy materials. Proposals must comply with SEC rules, Delaware law, and the company's bylaws. The announcement was made in a Form 8-K filed with the SEC by Interim CEO Blair Jordan on October 29, 2024.